Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
This Collection highlights the newest top-viewed content from Eye. Updated each month, we hope you enjoy reading this curated list of recent research. Eye aims to publish the latest developments in clinical and laboratory-based research, to provide practicing clinicians, healthcare workers and researchers with information on the latest developments in ophthalmology.
This is a special issue in a special year when we will reflect on the achievements (and challenges) of VISION 2020, a global WHO initiative that aimed to eliminate avoidable blindness.
Much progress has been done to improve health outcomes in people with glaucoma but it is humbling to reflect on the burden of glaucoma, still a leading cause of blindness in the developed world and much of it preventable. The challenge of preventing blindness and providing glaucoma care in low-to-middle outcome countries are gigantic.
In this special issue we have included some of the most relevant and exciting developments both in translational and clinical research. The efforts of many talented and dedicated individuals and organisations working towards prevention and treatment of glaucoma will continue to make a difference.
We would like to thank all authors for their generous contributions.
Anthony Khawaja and Augusto Azuara-Blanco
This collection highlights some of Eye’s published content contributed by authors from the US. Covering a range of topics on various fields within Ophthalmology, this Collection was curated by Eye’s Editor-in-Chief, Sobha Sivaprasad, and includes a selection of reviews and original research. Some of the reviews succinctly cover a large topic of interest while others provide perspectives on novel research areas or controversies. Original articles demonstrate diverse advances in research on disease mechanisms, therapeutics and basic science. The collection also includes an interesting article on Eponymous women in ophthalmology, emphasising syndromes with prominent eye manifestations named after female physicians!
Cochrane Eyes and Vision (CEV) is an international network of individuals working to prepare, maintain and promote access to systematic reviews of interventions and diagnostic tests to diagnose, treat or prevent eye diseases or visual impairment (https://eyes.cochrane.org/) . CEV has teamed up with Eye to produce clinical commentaries on selected Cochrane Reviews.
An expert clinical advisory group named Action on nAMD met on 16 March 2018 in Birmingham, UK, to explore and discuss multidisciplinary practice initiatives and service developments in the management of nAMD.
This collection provides a wide spectrum of reviews on prevalent eye conditions in Asia. Areas of focus include new insights on Pachychoroid, the much awaited role of artificial intelligence in the screening of diabetic retinopathy, control of myopia, acute angle closure glaucoma and infectious and non-infectious disease of particular relevance in Asia.
This selection of recently published manuscripts on age related macular degeneration (AMD) written by authors around the world covers a breadth of topics ranging from prediction models, risk factors including controversies in genetic testing, diagnostic dilemmas, evolution of terminologies defining the disease, evaluation of novel management options, treatment outcomes with currently available interventions and psychosocial impact of treatment burden.
The Cambridge Ophthalmological Symposium is a unique ophthalmological meeting. Held in St John’s College, Cambridge, it brings together basic scientists and clinicians to discuss a well defined topic in detail under the chairmanship of one of the leaders in that field. It has been running since 1971. In this web focus we are proud to highlight some recent contributions from the 2015 to 2018 Cambridge Ophthalmological Symposiums. Written by leaders in the field they describe some of the latest and most exciting research and clinical management in ocular oncology, myopia and infectious eye disease.